ORIC Pharmaceuticals’ (ORIC) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a report issued on Friday,Benzinga reports. They currently have a $21.00 price target on the stock. Other analysts also recently issued research reports about the stock. Wells Fargo & Company initiated coverage on shares of ORIC Pharmaceuticals in a […]
HC Wainwright reiterated their buy rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a report issued on Friday,Benzinga reports. They currently have a $21.00 price target on the stock. Other analysts also recently issued research reports about the stock. Wells Fargo & Company initiated coverage on shares of ORIC Pharmaceuticals in a […]
